Geneva, Switzerland and Boston, MA – August 28, 2018 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization…
Month: August 2018
ObsEva SA at Wedbush PacGrow Healthcare Conference August 14-15, 2018
Date & Time: August 14-15, 2018. ObsEva will present on Tuedsday August 14th 2018 at 8.00am Eastern Time (ET) Location: New York…
ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018
Geneva, Switzerland and Boston, MA – August 10, 2018 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and…
Half-Year Report 2018
ObsEva Reports Second Quarter 2018 Financial Results and Provides Business Update
Phase 2b EDELWEISS clinical trial of linzagolix (OBE2109) in endometriosis related pelvic pain achieved primary and secondary endpoints Chief Commercial…
Q2 2018 ObsEva SA Earnings Conference Call
Investors may participate by dialing (844) 419-1772 for U.S. callers and +1 (213) 660-0921 for international callers, and referring to…